Galderma presented eight abstracts in support of innovative aesthetics solutions and pipeline, including post-marketing safety surveillance study abstract named to “Best of Cosmetic Oral Abstracts” list

- Dysport^® is a prescription injection for temporary improvement in the look of moderate to severe glabellar lines – the first new muscle relaxant approved in China for eight years

Makers of the #1 and #2 Best-Selling Facial Cleansers Team Up with the Star to Lead a Dialogue Around Sensitive Skin

Ad hoc announcement pursuant to Art. 53 LR

Zug, Switzerland, April 23, 2026 – Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. 

FDA-approved EPSOLAY (benzoyl peroxide) Cream, 5% is now available by prescription across the U.S.